Literature DB >> 19209089

Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004.

Dana L Haberling1, Robert C Holman, Christopher D Paddock, Trudy V Murphy.   

Abstract

BACKGROUND: Infants aged <12 months have the highest rates of complications and death from pertussis of any age group. Factors that increase the risk of pertussis-related death in infants are not well defined.
METHODS: The US Multiple Cause-of-Death and Linked Birth/Infant Death databases were used for 1999 to 2004 to examine pertussis-related infant mortality rates and to obtain anonymous records of infants with pertussis listed as a cause of death and of surviving infants. Infant and maternal characteristics present at the time of birth for infants who died with pertussis were compared with those of surviving infants.
RESULTS: During 1999 to 2004, 91 infant deaths were reported with pertussis as a cause of death. All infants were 7 months or younger; 58% were age <2 months. The average annual infant mortality rate attributed to pertussis was 3.8 (95% CI: 3.0-4.6) per 1,000,000 live births, and 13.1 (95% CI: 9.8-17.1) per 1,000,000 live births for infants aged <2 months. Infant pertussis deaths showed an independent association with birth weight <2500 g, female sex, Apgar score <8, and mother with <12 years education. The mortality rate among Hispanic infants aged <2 months was 2.6 times greater than among non-Hispanic infants of similar age.
CONCLUSIONS: Ensuring pertussis booster vaccination of adults and adolescents in close contact with an infant is warranted to prevent transmission of pertussis to vulnerable infants, particularly infants too young to be immunized. Special emphasis should be given to women and infant settings in which the risk of infant pertussis death might be increased.

Entities:  

Mesh:

Year:  2009        PMID: 19209089     DOI: 10.1097/INF.0b013e31818c9032

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  27 in total

1.  Risk factors for infectious disease death among infants in the United States.

Authors:  Marissa K Person; Douglas H Esposito; Robert C Holman; Jason M Mehal; Barbara J Stoll
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

2.  Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts.

Authors:  A Orsi; C Azzari; E Bozzola; G Chiamenti; G Chirico; S Esposito; F Francia; P Lopalco; R Prato; R Russo; A Villani; E Franco
Journal:  J Prev Med Hyg       Date:  2018-06-01

3.  Evaluation of two vaccine education interventions to improve pertussis vaccination among pregnant African American women: A randomized controlled trial.

Authors:  Jennifer L Kriss; Paula M Frew; Marielysse Cortes; Fauzia A Malik; Allison T Chamberlain; Katherine Seib; Lisa Flowers; Kevin A Ault; Penelope P Howards; Walter A Orenstein; Saad B Omer
Journal:  Vaccine       Date:  2017-02-16       Impact factor: 3.641

4.  Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic.

Authors:  Elizabeth Rosenblum; Sarah McBane; Wendy Wang; Mark Sawyer
Journal:  Public Health Rep       Date:  2014-05       Impact factor: 2.792

5.  Maternal and neonatal vaccination protects newborn baboons from pertussis infection.

Authors:  Jason M Warfel; James F Papin; Roman F Wolf; Lindsey I Zimmerman; Tod J Merkel
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

6.  Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital.

Authors:  Chiara Di Camillo; Anna Chiara Vittucci; Livia Antilici; Claudia Ciarlitto; Giulia Linardos; Carlo Concato; Laura Lancella; Alberto Villani
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

7.  Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes.

Authors:  Julie H Shakib; Kent Korgenski; Xiaoming Sheng; Michael W Varner; Andrew T Pavia; Carrie L Byington
Journal:  J Pediatr       Date:  2013-07-26       Impact factor: 4.406

8.  The Impact of IgG transplacental transfer on early life immunity.

Authors:  Genevieve G Fouda; David R Martinez; Geeta K Swamy; Sallie R Permar
Journal:  Immunohorizons       Date:  2018-01-01

9.  Risk Factors for Pertussis Among Hispanic Infants: Metropolitan Portland, Oregon, 2010-2012.

Authors:  Kara M Levri; Laura Reynolds; Juventila Liko; Mary Dott; Byron F Robinson; Paul R Cieslak
Journal:  Pediatr Infect Dis J       Date:  2016-05       Impact factor: 2.129

10.  Cognitive Development One Year After Infantile Critical Pertussis.

Authors:  John T Berger; Michele E Villalobos; Amy E Clark; Richard Holubkov; Murray M Pollack; Robert A Berg; Joseph A Carcillo; Heidi Dalton; Rick Harrison; Kathleen L Meert; Christopher J L Newth; Thomas P Shanley; David L Wessel; Kanwaljeet J S Anand; Jerry J Zimmerman; Ronald C Sanders; Teresa Liu; Jeri S Burr; Douglas F Willson; Allan Doctor; J Michael Dean; Tammara L Jenkins; Carol E Nicholson
Journal:  Pediatr Crit Care Med       Date:  2018-02       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.